MedPath

mHealth Physical Activity Intervention for Young Cancer Survivors

Not Applicable
Active, not recruiting
Conditions
Cancer
Interventions
Behavioral: Physical Activity
Registration Number
NCT04765241
Lead Sponsor
AHS Cancer Control Alberta
Brief Summary

In this randomized controlled trial the investigators will determine whether a mobile health intervention can increase physical activity levels in AYA cancer survivors over a one year period. The investigators will recruit 320 cancer survivors in Alberta who were diagnosed with a first cancer between the ages of 15 to 39 years and are within one year of treatment completion. Participants will be randomized into either the control group (educational information) or the intervention group (educational information; personalized physical activity plan; activity tracker watch; access to a private, online survivor community; motivational text messages and check-in calls/e-mails). All participants will complete fitness testing and questionnaires at baseline, 6 months and 12 months. A final measurement at 24 months will test long-term effectiveness.

Detailed Description

Background:

There is a need for adolescent and young adult (AYA) cancer research because the number of new cancers in young people is increasing and the survivor population is growing. Interventions that try to reduce problems that affect people after cancer are particularly important since its treatments can have negative effects on survivors' physical and mental health even decades after diagnosis.

Aim:

Given the many positive effects of physical activity (e.g. improved fitness and quality of life), the study aims to encourage AYA cancer survivors to be more physically active as they shift from treatment to survivorship care. The main goal of this study is to see if a home-based, mobile health (mHealth) physical activity intervention can increase physical activity levels by at least 90 minutes/week compared to baseline in AYA cancer survivors.

Methods:

The investigators will conduct a two-center randomized controlled trial of 320 AYA cancer survivors. Participants (N=320) will be Albertan residents, diagnosed with a first cancer between the ages of 15 and 39 years, and within one year of cancer treatment completion. At the start of the study, participants will complete fitness testing and questionnaires. Participants will then be randomly put into either a control or intervention group. The control group will receive educational information only. The intervention group will also receive a personalized physical activity plan, an activity tracker watch, access to a private, online survivor community, motivational text messages and check-in calls/e-mails. Fitness testing and questionnaires will be repeated at 6 and 12 months to see if the intervention increased physical activity levels and improved health outcomes among the participants in the intervention group compared to controls. A final measurement at 24 months will test long-term use.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
287
Inclusion Criteria
  • Lives in Alberta
  • Diagnosed with invasive malignancy in Alberta
  • Completed active cancer directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention) in the last 12 months, except for "maintenance" therapy to prevent recurrences
  • Have the ability to read, write and speak English
  • Have access to the Internet on at least a weekly basis
  • Have a mobile phone with a text messaging plan
  • Willing to be randomized to either arm.
Exclusion Criteria
  • Health problems which preclude the ability to walk for physical activity, as measured by the Physical Activity Readiness Questionnaire (PAR-Q)
  • Currently pregnant or planning to become pregnant within the next 6 months
  • Currently taking part in > 300 minutes/week of moderate-to-vigorous intensity physical activity on a regular basis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
mHealth Physical Activity InterventionPhysical ActivityThe intervention arm will receive a 12 month mobile health (mHealth) physical activity intervention with a goal of increasing their moderate-vigorous intensity physical activity levels by 90 minutes per week above baseline
Primary Outcome Measures
NameTimeMethod
Changes in weekly minutes of moderate-vigorous intensity physical activityBaseline, 6 months, 12 months, 24 months

Measured by Actigraph

Secondary Outcome Measures
NameTimeMethod
Changes in upper body muscular enduranceBaseline, 6 months,12 months

Measured in kilograms using the maximum number of chest press repetitions completed at 50-70% of estimated 1-RM

Changes in lower body muscular enduranceBaseline, 6 months,12 months

Measured in kilograms using the maximum number of leg press repetitions completed at 50-70% of estimated 1-RM

Changes in the Short Form 36 (SF-36) Mental Health Component subscaleBaseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better mental health

Changes in weekly minutes of sedentary timeBaseline, 6 months,12 months

Measured by Actigraph

Changes in the Pittsburgh Sleep Quality Index (PSQI) Global Sleep Quality ScoreBaseline, 6 months,12 months

Global score range is 0 to 23 where higher scores indicate worse sleep quality

Changes in upper body muscular strengthBaseline, 6 months,12 months

Measured in kilograms using an 8-10 repetition maximum (RM) chest press test used to predict 1-RM

Changes in weightBaseline, 6 months,12 months

Measured in kilograms

Changes in the Short Form 36 (SF-36) Physical Health Component subscaleBaseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better physical health

Changes in the Short Form 36 (SF-36) Bodily Pain subscaleBaseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate less pain

Changes in the Short Form 36 (SF-36) Social Functioning subscaleBaseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Changes in the Cancer Distress Scales for AYAs Impact of Cancer subscaleBaseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Comments From Others subscaleBaseline, 6 months,12 months

Score range is from 0 to 16 where higher scores indicate poorer cognition

Changes in waist and hip circumferenceBaseline, 6 months,12 months

Measured in centimeters

Changes in grip strengthBaseline, 6 months,12 months

Measured in kilograms using a hand dynamometer

Changes in frailtyBaseline, 6 months,12 months

Defined according to the Fried phenotype which takes into account low lean muscle mass, exhaustion, low energy expenditure, walking limitations, and weakness

Changes in the Short Form 36 (SF-36) Physical Functioning subscaleBaseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Changes in the Short Form 36 (SF-36) Role-emotional subscaleBaseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Changes in the Short Form 36 Mental Health subscaleBaseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better mental health

Changes in the Cancer Distress Scales for AYAs Education subscaleBaseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Changes in the Cancer Distress Scales for AYAs Practical subscaleBaseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Changes in lower body muscular strengthBaseline, 6 months,12 months

Measured in kilograms using an 8-10 repetition maximum (RM) leg press test used to predict 1-RM

Changes in the Comprehensive Score for Financial Toxicity (COST)Baseline, 6 months,12 months

Score range is from 0 to 44 where higher scores indicate better financial wellbeing

Changes in weekly minutes of sleepBaseline, 6 months,12 months

Measured by Actigraph

Changes in body mass index (BMI)Baseline, 6 months,12 months

Measured by combining height (meters) and weight (kilograms) and reported in kg/m2

Changes in cardiorespiratory fitnessBaseline, 6 months,12 months

Measured by peak oxygen consumption in absolute (L/min) values using the incremental Balke and Ware treadmill test with direct measures of gas exchange and ventilation

Changes in the Short Form 36 (SF-36) Vitality subscaleBaseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher vitality

Changes in the Cancer Distress Scales for AYAs Physical subscaleBaseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Changes in the Cancer Distress Scales for AYAs Cognitive subscaleBaseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Changes in the Cancer Distress Scales for AYAs Cancer Worry subscaleBaseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Changes in the Cancer Distress Scales for AYAs Employment subscaleBaseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Changes in the Short Form 36 (SF-36) Role-physical subscaleBaseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Changes in the Short Form 36 (SF-36) General Health subscaleBaseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better health

Changes in the Cancer Distress Scales for AYAs Emotional subscaleBaseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Changes in the Functional Assessment of Cancer Therapy Fatigue (FACT-F)Baseline, 6 months,12 months

Score range is from 0 to 52 where higher scores indicate less fatigue

Changes in the Functional Assessment of Cancer Therapy Cognitive Function Perceived Cognitive Impairment subscaleBaseline, 6 months,12 months

Score range is from 0 to 80. Higher scores indicate poorer quality of life.

Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Perceived Cognitive Abilities subscaleBaseline, 6 months,12 months

Score range is from 0 to 36 where higher scores indicate poorer cognition

Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Impact on Quality of Life subscaleBaseline, 6 months,12 months

Score range is from 0 to 16 where higher scores indicate poorer cognition

Trial Locations

Locations (1)

Arthur J.E. Child Comprehensive Cancer Centre

🇨🇦

Calgary, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath